These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30577317)

  • 21. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization in heart transplant recipients: Who, when, and how.
    Shah KS; Patel J
    Clin Transplant; 2019 Aug; 33(8):e13639. PubMed ID: 31206862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ; Kamoun M; Chan KM
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Efficacy of Immunoadsorption in Heart Transplantation Program.
    Gazdic T; Malek I; Pagacova L; Slavcev A; Voska L; Hegarova M; Hoskova L; Kubanek M; Pirk J
    Transplant Proc; 2016 Oct; 48(8):2792-2796. PubMed ID: 27788819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.
    Farrero Torres M; Pando MJ; Luo C; Luikart H; Valantine H; Khush K
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
    Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-mediated rejection following transplantation from an HLA-identical sibling.
    Grafft CA; Cornell LD; Gloor JM; Cosio FG; Gandhi MJ; Dean PG; Stegall MD; Amer H
    Nephrol Dial Transplant; 2010 Jan; 25(1):307-10. PubMed ID: 19846396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antibody profiling in thoracic transplantation undergoing desensitization therapy.
    Zeevi A; Lunz J
    Curr Opin Organ Transplant; 2012 Aug; 17(4):416-22. PubMed ID: 22790076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
    Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study.
    Nguyen LS; Salem JE; Bories MC; Coutance G; Amour J; Bougle A; Suberbielle C; Kheav VD; Carmagnat M; Rouvier P; Kirsch M; Varnous S; Leprince P; Saheb S
    Front Immunol; 2021; 12():659303. PubMed ID: 34305891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Pretransplant Panel-Reactive Antibody Level on Renal Graft Survival in Patients With a Negative Crossmatch and No Donor-Specific Antibody.
    Jun KW; Kim MH; Hwang JK; Kim SD; Park SC; Won YS; Moon IS; Chung BH; Choi BS; Yang CW; Kim YS; Kim JI
    Transplant Proc; 2016 Apr; 48(3):770-2. PubMed ID: 27234732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influences of Pre-formed Donor-Specific Anti-Human Leukocyte Antigen Antibodies in Living-Donor Renal Transplantation: Results With Graft Immunocomplex Capture Fluorescence Analysis.
    Nakamura T; Ushigome H; Watabe K; Imanishi Y; Masuda K; Matsuyama T; Harada S; Koshino K; Iida T; Nobori S; Yoshimura N
    Transplant Proc; 2017 Jun; 49(5):955-958. PubMed ID: 28583566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of anti-HLA antibodies associated with ventricular assist device use in pediatric patients: A United Network for Organ Sharing database analysis.
    Magdo HS; Schumacher KR; Yu S; Gajarski RJ; Friedland-Little JM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28568969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
    Nwakanma LU; Williams JA; Weiss ES; Russell SD; Baumgartner WA; Conte JV
    Ann Thorac Surg; 2007 Nov; 84(5):1556-62; discussion 1562-3. PubMed ID: 17954062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Simultaneous Pancreas-Kidney Re-transplantation in a Highly Human Leukocyte Antigen-Sensitized Patient.
    Kykalos S; Wunsch A; Klein T; Viebahn R; Schenker P
    Transplant Proc; 2017 Sep; 49(7):1652-1655. PubMed ID: 28838458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.